Critical care already contributes more than half of BPL’s revenue, while imaging and acquisitions are expected to strengthen its expansion: इस घटनाक्रम की आधिकारिक सूचना जारी की गई है। Guruswamy Krishnamoorthy, CEO, BPL Medical Technologies Pvt. Ltd
## घटनाक्रम का विस्तृत विवरण
Critical care already contributes more than half of BPL’s revenue, while imaging and acquisitions are expected to strengthen its expansion
Guruswamy Krishnamoorthy, CEO, BPL Medical Technologies Pvt. Ltd
BPL Medical Technologies is looking to quadruple its revenue to around ₹2,000 crore by 2032, with critical care and imaging expected to drive the next phase of growth as the medical-device maker expands beyond its traditional cardiology base.
## मुख्य सत्यापित तथ्य व बिंदु
• Speaking to businessline , Guruswamy Krishnamoorthy, CEO, BPL Medical Technologies Pvt. Ltd more than 50 per cent of BPL’s revenue currently comes from critical care, which has emerged as a core business for the company after a decade of expansion into anaesthesia, patient monitoring, ventilators, and infusion pumps. Imaging, meanwhile, is an evolving business that the company expects to play a significantly larger role in its next growth phase. • Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments. • We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
## तथ्यात्मक संदर्भ व पुष्टि
यह विशेष रिपोर्ट आधिकारिक सार्वजनिक दस्तावेजों और पुष्ट सूचनाओं के आधार पर तैयार की गई है। संपादकीय सत्यापन मानकों के अनुसार BusinessLine द्वारा जारी सत्यापित तथ्यों को बिना किसी अनुमान या अप्रमाणित दावों के प्रस्तुत किया गया है।
## घटनाक्रम का विस्तृत विवरण
Critical care already contributes more than half of BPL’s revenue, while imaging and acquisitions are expected to strengthen its expansion
Guruswamy Krishnamoorthy, CEO, BPL Medical Technologies Pvt. Ltd
BPL Medical Technologies is looking to quadruple its revenue to around ₹2,000 crore by 2032, with critical care and imaging expected to drive the next phase of growth as the medical-device maker expands beyond its traditional cardiology base.
## मुख्य सत्यापित तथ्य व बिंदु
• Speaking to businessline , Guruswamy Krishnamoorthy, CEO, BPL Medical Technologies Pvt. Ltd more than 50 per cent of BPL’s revenue currently comes from critical care, which has emerged as a core business for the company after a decade of expansion into anaesthesia, patient monitoring, ventilators, and infusion pumps. Imaging, meanwhile, is an evolving business that the company expects to play a significantly larger role in its next growth phase. • Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments. • We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
## तथ्यात्मक संदर्भ व पुष्टि
यह विशेष रिपोर्ट आधिकारिक सार्वजनिक दस्तावेजों और पुष्ट सूचनाओं के आधार पर तैयार की गई है। संपादकीय सत्यापन मानकों के अनुसार BusinessLine द्वारा जारी सत्यापित तथ्यों को बिना किसी अनुमान या अप्रमाणित दावों के प्रस्तुत किया गया है।
पूरी खबर, विस्तृत घटनाक्रम और विश्लेषण पढ़ने के लिए क्लिक करें
